Patents

Title

Publication number

Applicant*

Triazole derivatives as tankyrase inhibitors

WO 2018118868 A1

Oslo Univ Hospital, FVB, Univ Oulo

Selective inhibitors of genotoxic stress-induced IKK/NF-kB pathways

WO 2018087389 A1

MDC, FVB

Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

WO 2018041985 A1

FVB, LMU

Molecular sensor for NMR/MRI based on analyte-dependent spectral changes of temporarily encapsulated hyperpolarized 129Xe

WO 2018020025 A1

TUM, FVB

Unusual substrates of tubulin tyrosine ligase

WO 2017186855 A1

FVB, LMU

Antagonists of the thyroid-stimulating hormone receptor (TSHR)

WO 2017186793 A1

FVB

Means and methods for site-specific functionalization of polypeptides

US 20170349625 A1, EP 3212659 A1, CA 2964837 A1, AU 2015340591 A1

LMU, FVB

Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same

US 20180051025 A1, EP 3061761 A1, EP 3275885 A1

FVB, MDC

Inhibitors for inhibiting tumor metastasis

US 20170320910 A1, EP 3230300 A1

FVB, Univ zu Köln

LRRC8 proteins and protein complexes and methods for identification of channel modulators

US 9927423 B2, EP 2919009 A1

FVB, MDC

Potassium channel KCNQ5 and sequences encoding the same

US 6649371 B1, US 7288630 B2, JP 4833467 B2

FVB, MDC

Potassium channels and genes encoding these potassium channels

US 7378497 B2, EP 1147134 B1

FVB, MDC

Structural mimetics of proline-rich peptides and use thereof

US 9242985 B2, JP 2017165761 A, EP 2747764 B1

FVB, Univ zu Köln

N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease

US 9102667 B2

MDC, FVB

Induction of alpha helix conformations in proteins and peptides

US 8815932 B2, EP 2451815 B1

Univ zu Köln, FVB

Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

US 8741259 B2, US 9187457 B2, US 9296729 B2, US 9458141 B2, JP 5718233 B2, JP 2012506841 A, EP 2358684 B8, AU 2008363295 B2, AU 2015204281 B2, AU 2016204845 B2

US Health, FVB

Structural mimetics of proline-rich peptides and the pharmaceutical use thereof

US 8242105 B2, JP 5588172 B2, EP 2094711 B8

FVB

*FVB - Forschungsverbund Berlin e.V. (for its Leibniz-Forschungsinstitut für Molekulare Pharmakologie); LMU - Ludwig-Maximilians-Universität München; MDC - Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft; Oslo Univ Hospital - Oslo University Hospital HF; TUM - Technische Universität München; Univ Oulo - University of Oulo; Univ zu Köln - Universität zu Köln; US Health - The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)
info(at)fmp-berlin.de

Diese Website verwendet Cookies zur Verbesserung des inhaltlichen Angebots. Datenschutz OK